The density of COX-2, the inflammatory end-product after ischemia, in the infarcted hemisphere was 1.6-fold higher in the control group than the fimasartan-treated group (P < 0.05; Figures 5(c) and 5(e)). The gene discussed is PTGS2; the disease is ischemia.